Welcome to LookChem.com Sign In|Join Free

CAS

  • or

526221-05-6

Post Buying Request

526221-05-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

526221-05-6 Usage

Functional Groups

Methyl ester, ethoxy, hydroxy

Structure

A benzene ring with a dioxole group at positions 1 and 3, a carboxylic acid group at position 5, an ethoxy group at position 2, and a hydroxy group at position 7

Molecular Weight

238.19 g/mol

Appearance

Solid or crystalline

Solubility

Soluble in organic solvents like methanol, ethanol, and acetone

Stability

Stable under normal temperature and pressure, but sensitive to heat, light, and moisture

Reactivity

Can undergo reactions such as esterification, hydrolysis, and substitution

Applications

Used as a building block in the synthesis of various organic compounds, particularly in the pharmaceutical and chemical industries

Biological and Pharmacological Activities

Potential activities, may be used in the development of new drugs or as a research tool in medicinal chemistry

Safety

Handle with care, avoid contact with skin and eyes, use appropriate protective equipment

Storage

Store in a cool, dry, and well-ventilated area, away from heat and light sources

Environmental Impact

May be harmful to aquatic life, dispose of according to local regulations

Regulatory Status

May be subject to specific regulations depending on the intended use and location

Check Digit Verification of cas no

The CAS Registry Mumber 526221-05-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,2,6,2,2 and 1 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 526221-05:
(8*5)+(7*2)+(6*6)+(5*2)+(4*2)+(3*1)+(2*0)+(1*5)=116
116 % 10 = 6
So 526221-05-6 is a valid CAS Registry Number.

526221-05-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 2-ethoxy-7-hydroxy-1,3-benzodioxole-5-carboxylate

1.2 Other means of identification

Product number -
Other names 1,3-Benzodioxole-5-carboxylic acid,2-ethoxy-7-hydroxy-,methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:526221-05-6 SDS

526221-05-6Downstream Products

526221-05-6Relevant articles and documents

Added Alkane Allows Thermal Thinning of Supramolecular Columns by Forming Superlattice?-An X-ray and Neutron Study

Yen, Ming-Huei,Chaiprapa, Jitrin,Zeng, Xiangbing,Liu, Yongsong,Cseh, Liliana,Mehl, Georg H.,Ungar, Goran

, p. 5757 - 5760 (2016)

We report a columnar superlattice formed by blends of dendron-like Li 3,4,5-Tris(n-Alkoxy)benzoates with n-Alkanes. Without the alkane, the wedge-shaped molecules form liquid crystal columns with 3 dendrons in a supramolecular disk. The same structure exi

One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA

Zhang, Dapeng,Atochina-Vasserman, Elena N.,Maurya, Devendra S.,Huang, Ning,Xiao, Qi,Ona, Nathan,Liu, Matthew,Shahnawaz, Hamna,Ni, Houping,Kim, Kyunghee,Billingsley, Margaret M.,Pochan, Darrin J.,Mitchell, Michael J.,Weissman, Drew,Percec, Virgil

, p. 12315 - 12327 (2021/08/20)

Efficient viral or nonviral delivery of nucleic acids is the key step of genetic nanomedicine. Both viral and synthetic vectors have been successfully employed for genetic delivery with recent examples being DNA, adenoviral, and mRNA-based Covid-19 vaccines. Viral vectors can be target specific and very efficient but can also mediate severe immune response, cell toxicity, and mutations. Four-component lipid nanoparticles (LNPs) containing ionizable lipids, phospholipids, cholesterol for mechanical properties, and PEG-conjugated lipid for stability represent the current leading nonviral vectors for mRNA. However, the segregation of the neutral ionizable lipid as droplets in the core of the LNP, the "PEG dilemma", and the stability at only very low temperatures limit their efficiency. Here, we report the development of a one-component multifunctional ionizable amphiphilic Janus dendrimer (IAJD) delivery system for mRNA that exhibits high activity at a low concentration of ionizable amines organized in a sequence-defined arrangement. Six libraries containing 54 sequence-defined IAJDs were synthesized by an accelerated modular-orthogonal methodology and coassembled with mRNA into dendrimersome nanoparticles (DNPs) by a simple injection method rather than by the complex microfluidic technology often used for LNPs. Forty four (81%) showed activity in vitro and 31 (57%) in vivo. Some, exhibiting organ specificity, are stable at 5 °C and demonstrated higher transfection efficiency than positive control experiments in vitro and in vivo. Aside from practical applications, this proof of concept will help elucidate the mechanisms of packaging and release of mRNA from DNPs as a function of ionizable amine concentration, their sequence, and constitutional isomerism of IAJDs.

Extraordinary Acceleration of Cogwheel Helical Self-Organization of Dendronized Perylene Bisimides by the Dendron Sequence Encoding Their Tertiary Structure

Wang, Li,Wang, Li,Partridge, Benjamin E.,Huang, Ning,Olsen, James T.,Sahoo, Dipankar,Zeng, Xiangbing,Ungar, Goran,Ungar, Goran,Graf, Robert,Spiess, Hans W.,Percec, Virgil

, p. 9525 - 9536 (2020/06/27)

The cogwheel model of hierarchical self-organization provides a route to highly ordered crystalline helical columnar hexagonal arrays of perylene bisimides (PBIs) conjugated to (3,4,5)-dimethyloctyl (racemic dm8*, r) minidendrons. Cogwheel PBIs assemble with identical structural order irrespective of molecular chirality to generate helical columns jacketed with an alkyl coat with length equal to half the helical pitch, exhibiting helical deracemization in the crystal state. These assemblies were accessible only via annealing or cooling and reheating at 1 °C/min. Recently it was discovered that hybrid rr8 sequence-defined dendrons with r and linear n-octyl (8) chains enabled the formation of the cogwheel phase at 10 °C/min upon heating but not cooling. Here we report four libraries of hybrid PBIs with sequence-defined dendrons containing r and n-alkyl (CnH2n+1) chains with n = 6, 7, 9, and 10. Structural analysis of these libraries by fiber X-ray diffraction and differential scanning calorimetry reveals that the 9r9 sequence enables an extraordinary acceleration of cogwheel assembly at rates of up to 50 °C/min on heating and cooling, providing, to the best of our knowledge, the fastest crystallizing supramolecular or covalent macromolecule known. Solid-state NMR studies help to elucidate this unexpected and unprecedented extraordinary acceleration of hierarchical self-organization, which arises from a combination of crystal packing of the ideal tertiary structure and alkyl chain dynamics. This general model raises questions about the use of achiral motifs to achieve high structural order in chiral systems and the need for disorder to create order in complex biological and bioinspired synthetic systems.

Drug compound for treating hepatopathy and application thereof

-

Paragraph 0230-0232, (2019/10/15)

The invention discloses a drug compound for treating hepatopathy and application thereof. The drug compound specifically serves as a compound shown in general formula (I) or an optical isomer or a pharmaceutically-acceptable salt of the compound. The compound or the optical isomer or the pharmaceutically-acceptable salt of the compound has a good curative effect and low toxicity on hepatopathy, especially fatty liver. Experiments show that the compound has an obvious protective effect on zebrafish nonalcoholic fatty liver, so that the drug compound has a good application prospect in medicinesfor treatment or prevention of hepatopathy, especially fatty liver or liver fibrosis or liver cirrhosis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 526221-05-6